Showing results (321-330 of 411) with videos related to
Sort By:
Pageof 42
Ageing Research Reviews|April 29, 2021
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidenceHarald Hampel, Robert Nisticò, Nicholas T Seyfried, et al.Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.Archives of Neurology|August 8, 2002
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231Katharina Buerger, Raymond Zinkowski, Stefan J Teipel, et al.Pharmacological Research|February 20, 2018
Precision pharmacology for Alzheimer's diseaseHarald Hampel, Andrea Vergallo, Lisi Flores Aguilar, et al.Journal of Alzheimer'S Disease : JAD|February 8, 2014
Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter studyIngo Kilimann, Michel Grothe, Helmut Heinsen, et al.Acta Neuropathologica|November 30, 2018
Current state of Alzheimer's fluid biomarkersJosé Luis Molinuevo, Scott Ayton, Richard Batrla, et al.Neurology|March 1, 2013
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCIStephanie J B Vos, Ineke A van Rossum, Frans Verhey, et al.Progress in Neurobiology|September 20, 2011
Prevention trials in Alzheimer's disease: an EU-US task force reportBruno Vellas, Paul S Aisen, Cristina Sampaio, et al.Journal of Alzheimer'S Disease : JAD|August 29, 2016
Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric InpatientsKerstin Ritter, Catharina Lange, Martin Weygandt, et al.Neurobiology of Aging|January 24, 2007
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter studyPiotr Lewczuk, Johannes Kornhuber, Hugo Vanderstichele, et al.Pageof 42